The department provides innovative and comprehensive care for patients with complex diseases of the heart, blood vessels, and circulatory system. The research programme enables the department to transfer the latest in prevention, diagnosis, treatment and care directly to patients.
Areas of interest
- Ischemic heart disease – non-invasive and invasive interventions
- Advanced heart disease and heart failure
- Cardiac arrhythmias, clinical syndromes and basic science
- Structural heart disease and cardiovascular congenital/hereditary diseases
- Imaging – Echocardiography, Multislice CT-scan and Magnetic Resonanse Imaging
- Stem cell and cardiac regenerative therapy
Collaboration with external partnersThe department collaborates with all the invasive cardiology departments in Denmark and most of Scandinavia. Secondly, there is a close collaboration with many international heart centres across Europe and the US.
Among these are
- Brigham & Women’s Hospital, Boston, USA.
- Johns Hopkins University, Baltimore, USA
- Western Infirmary, Glasgow University
- Duke University, Durham, NC, USA.
- Medical University of Vienna, Austria.
- European Society of Cardiology
- Basel University Hospital, Switzerland
- Department of Cardiology of the Catharina Hospital, Eindhoven, Netherlands
- Cardiovascular Center, Aalst, Belgium.
- Thoraxcenter Rotterdam, The Netherlands
- Bern University Hospital, Switzerland
- Dept. of Cardiology, Stanford University, Palo Alto, California
Awards and Major fundingThe Danish Arrhythmia and Research Centre (DARC) is a collaboration between the Heart Centre and the Department of Biomedical Sciences, Panum Institute, University of Copenhagen and is funded by the Danish National Research Foundation. The DARC aims at clarifying how molecular alterations in the cardiac muscle cells cause electrical instability and generate arrhythmia.
EDITORS (Eastern Denmark Initiative To imprOve Revascularization Strategies) is a collaboration between the Department of Cardiology, Rigshospitalet and Gentofte Hospital, Copenhagen and is funded by the Danish Council for Strategic Research with DKK 20 million.
DANISH(A danish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillator in patients with non-ischemic Systolic Heart failure on mortality) is funded with DKK 15 million by the Danish Heart Foundation and the Medtronic and St Jude medical companies.
The VOLCANO trialValve replacement in patients with severe aOrtic vaLve stenosis comparing transCAtheter and surgical implaNtatiOn. A National randomized clinical trial of trans-catheter aortic valve implantation (TAVI) compared with conventional surgical aortic valve replacement (SAVR) is being funded with DKK 8 mill by the Danish Heart Foundation.